118th Congress Health
H.R. 6094: Providing Realistic Opportunity To Equal and Comparable Treatment for Rare Act
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Neal Dunn R-FLOriginal
- Mike Kelly R-PAOriginal
- Mike Thompson D-CAOriginal
- Dean Phillips D-MN
- Melanie Stansbury D-NM
- Gus Bilirakis R-FL
- Mikie Sherrill D-NJ
- Brian Fitzpatrick R-PA
- Eleanor Norton D-DC
- Steve Cohen D-TN
- Don Bacon R-NE
- Lizzie Fletcher D-TX
- Donald Davis D-NC
- Mariannette Miller-Meeks R-IA
- Lori Trahan D-MA
- Shri Thanedar D-MI
- Mike Quigley D-IL
- Josh Gottheimer D-NJ
- August Pfluger R-TX
- Salud Carbajal D-CA
- David Trone D-MD
- Paul Tonko D-NY
- Richard Hudson R-NC
- Joe Neguse D-CO
- Jake Auchincloss D-MA
- Sheila Cherfilus-McCormick D-FL
Who scored on this bill
- 1Doris Matsui SponsorDrew cross-party cosponsors, introduced, reached a cosponsor milestone3 events+12
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Doris Matsui
History
- Introduced in the House by Doris Matsui.
Show the full action history (4 actions)
- Referred to the Subcommittee on Health.
- Referred to the Subcommittee on Health.
- Introduced in House
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.